Find Support With:
Abnormal Newborn Screening Results and Additional Testing
If your baby’s newborn screening results are abnormal, your baby will need to have another test. Not every abnormal result means your baby has a disorder. It is important to have quick follow-up testing. Without treatment, VLCAD Deficiency can result in harmful effects soon after birth.
The Utah Newborn Screening Program will contact you and your child’s pediatrician for blood and urine testing.
The Metabolic Clinic at Primary Children’s Hospital cares for babies diagnosed with VLCAD Deficiency.
About VLCAD Deficiency
VLCAD Deficiency is a fatty acid oxidation disorder. People affected by VLCAD Deficiency are not able to break down certain fats for the energy their body needs.
If untreated, VLCAD Deficiency can cause brain damage and even death. However, if VLCAD is detected early and proper treatment is begun, children with VLCAD can often lead healthy lives.
Frequency
VLCAD Deficiency affects approximately 1 in 30,000 babies in the United States.
Condition Type
VLCAD Deficiency is a Fatty Acid Oxidation Disorder.
Also Known As
VLCADD, Very Long-Chain Acyl-CoA Dehydrogenase Deficiency, Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency, Acyl-CoA Dehydrogenase Very Long-Chain Deficiency, VLCAD-C, VLCAD-H, ACADVL, LCAD, C14:1
More Information
For Parents
For Physicians
- ACMG ACT Sheet opens in a new tab
- Genetics Home Reference opens in a new tab
- VLCAD Protocol opens in a new tab (New England Consortium of Metabolic Programs)